Dyne Therapeutics, Inc. 4

Carlo Incerti received an option award for 35,152 shares of Dyne Therapeutics, Inc. common stock at a $17.04 exercise price on June 5, 2026.

On June 5, 2026, insider Carlo Incerti of Dyne Therapeutics, Inc. received a grant of stock options representing the right to purchase 35,152 shares of Dyne common stock at an exercise price of $17.04 per share. This is a compensatory award (coded as an acquisition) with no immediate cash outlay and a scheduled vesting in full on the earlier of June 5, 2027 or the date of Dyne’s 2027 Annual Meeting of Stockholders, subject to his continued service. Following this grant, Incerti’s derivative holdings increased by 35,152 option shares, which will only have realizable value if the market price of the common stock exceeds the $17.04 exercise price at or after vesting.

Filing Facts

CIK

1818794

Ticker

DYN

Form

4

Source Type

sec

Accession

0001193125-26-264019

Alert Tier

5